According to the report, the global HbA1c testing device market accounted for around USD 1.20 billion in 2015 and is expected to reach approximately USD 2.20 billion by 2021, growing at a CAGR of around 11 % between 2016 and 2021.
Hemoglobin is the iron containing and oxygen transporting metalloprotein found in the red blood cells of vertebrates. HbA1c is a form of hemoglobin to which glucose binds in the red blood cells and it is also referred as glycated hemoglobin. Diabetes mellitus is a metabolic disorder characterized by disturbances of carbohydrate and chronic hyperglycemia resulting from defects in insulin secretion. The long–term effects of diabetes mellitus include the development of nephropathy, neuropathy, and retinopathy. People with diabetes mellitus are also at a risk of cerebrovascular disease, peripheral arterial, and cardiac diseases. HbA1c is an ideal marker for diabetes monitoring and diagnosis. HbA1c molecule reflects average glucose level over the previous eight to 12 weeks.
Request Free Sample copy of Research Report @ https://www.zionmarketresearch.com/sample/hba1c-testing-device-market
The increasing prevalence of raised blood sugar or hyperglycemia is a common effect of uncontrolled diabetes mellitus and it has affected around 422 million people in 2014. This global prevalence of diabetes has increased by 8.5% in 2014. Thus, the market for the HbA1c testing device is propelled by rising diabetic adult population and rising prevalence of diabetes in middle and low-income countries. Moreover, HbA1c testing device market is rapidly growing due to rising awareness preventive care and diabetes management. Diabetes has emerged as one of the most challenging public health problems and it is a major cause of stroke, blindness, heart attacks and kidney failure. Thus, diabetic patient education becomes a prime component of diabetes management. In addition, technological advancement in HbA1c measurement is continuously responsible for the growth of HbA1c testing device market. Recently, HbA1c testing has been incorporated into point of care devices. However, the cost of the device and low diagnostic performance of the test in pregnancy, elderly and non-Hispanic black population may hamper the growth of HbA1c testing device market. Nonetheless, untapped market and rapidly rising use of the HbA1c test for diabetes management are projected to generate opportunity in the forecast period.
Based on the device type, the market of the HbA1c testing device has been bifurcated into the handheld device and bench-top device. In 2015, bench-top device segment dominated the market for a HbA1c testing device with major market share. In the forecast period, handheld device segment is expected to exhibit noticeable growth due to rising awareness of personal care.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/hba1c-testing-device-market
Technology type segment has been further classified into ion-exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay and other. In 2015, affinity binding chromatography segment dominated the HbA1c testing device market and the dominance of affinity binding chromatography is due to widely use of technology in device manufacturing. As a result of this, it is expected to generate new opportunities in the forecast period. Affinity binding chromatography technology uses the principle of affinity and high-performance liquid chromatography (HPLC). Affinity binding chromatography requires no sample pretreatment to remove the labile.
Based on the end user type, the HbA1c testing device market is classified into hospitals, home care, research institutions and diagnostic laboratory. The diagnostic laboratory was the largest segment in 2015 and it is expected to show significant growth in the forecast period.
Browse detail report with in-depth TOC @ https://www.zionmarketresearch.com/report/hba1c-testing-device-market
Based on the regional, the HbA1c testing device market is classified into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America dominated the HbA1c testing device market in 2015 with around 40% market share. North America HbA1c testing device market was driven by well-developed healthcare infrastructure and rising prevalence of diabetes mellitus. Europe and Asia Pacific market are projected to show healthy growth in coming years.
Key operating players in HbA1c testing device market include Transasia Biomedicals Ltd., Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc.
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
4283, Express Lane,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651